Making Healthcare Better: The Manufacturing Technologies Powering MedTech Innovation
Stryker highlights how advanced manufacturing, robotics, AI and digital twins are reshaping MedTech, accelerating product cycles and enabling patient‑specific solutions. Additive manufacturing and 3D printing now move concepts to production in weeks, while digital twins create precise virtual replicas for safer surgeries. Collaboration with Irish research centres, universities and government fuels talent development and rapid innovation. The company’s AMagine Institute exemplifies Ireland’s role as a global hub for next‑generation medical technology.
Amgen Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods
Amgen is positioning its investigational bispecific antibody‑peptide, MariTide, as a differentiated obesity therapy by offering monthly, bimonthly, or quarterly dosing without compromising efficacy. Phase II data revealed an average weight loss of up to 20 % after 52 weeks, and the company...
The Biggest Biotech Funding Rounds in January 2026
In January 2026 biotech firms secured record capital, with Parabilis Medicines leading private rounds at $305 million and Aktis Oncology topping public offerings at $365.4 million. Private fundraising totaled $2.986 billion across 31 rounds, while public markets raised $1.67 billion from nine offerings. Oncology and...
Oracle Life Sciences AI Data Platform Unites Data and Agentic Intelligence to Accelerate Medical Breakthroughs
Oracle introduced the Oracle Life Sciences AI Data Platform, a generative AI‑enabled solution that consolidates diverse life‑science datasets and applies agentic AI to accelerate research, clinical trials, and commercialization. The platform offers out‑of‑the‑box AI agents and tools for label expansion,...
HighRes and Opentrons Announce Partnership to Launch AI Agent-to-Agent Lab Automation Workflow
HighRes and Opentrons have formed a strategic partnership to create the industry’s first AI agent‑to‑agent laboratory automation workflow, linking software‑driven experiment design directly to physical execution. The integration combines Opentrons’ modular robotic platforms and AI‑enabled protocol tools with HighRes’ orchestration...
GSK Says No to GLP-1s, Prioritizes ‘Downstream Effects’ of Obesity
GSK’s new CEO Luke Miels announced the company will not pursue GLP‑1 obesity drugs, citing a crowded market and pipeline misalignment. Instead, GSK is concentrating on the downstream complications of obesity, particularly liver disease, after acquiring Boston Pharmaceuticals’ efimosfermin alfa...
Lilly’s GLP-1s Mounjaro, Zepbound Push Revenue up 46% in Q4
Eli Lilly reported fourth‑quarter revenue of $19.3 billion, driven by a 46 % surge in volume of its GLP‑1 drugs Mounjaro and Zepbound. Earnings per share rose to $7.54, comfortably beating the $6.91 consensus. The two drugs together generated $11.7 billion, lifting the company’s...
Green Chemistry Breakthrough: Friendly Bacteria Reveal Hidden Metabolic Pathways in Plant Cell Cultures
Scientists at Tokyo University of Science have shown that endophytic bacteria can coexist with plant cell cultures and unlock dormant metabolic pathways. Co‑culturing tobacco BY‑2 cells with Delftia sp. BR1R‑2 triggered a surge in acetophenone derivatives and altered phenolic profiles...
QT Sense Secures €4M ($4.7M USD) for Nanodiamond-Based Cellular Sensing Platform
QT Sense, a Dutch biotech startup, closed a €4 million seed round led by Cottonwood Technology Fund, supplemented by an ONCO‑Q grant and the Quantum Forward Challenge. The capital will accelerate development of Quantum Nuova, a nanodiamond‑based quantum‑sensing platform that provides real‑time,...
Women in STEM: Cultivating Scientific Confidence
Elisabeth Gardiner, CSO of Tevard Biosciences, warned that women remain vastly under‑represented in pharmaceutical STEM roles, occupying only 20‑30% of such positions despite comprising half of the U.S. workforce. She highlighted a "confidence paradox" where girls' interest in STEM has...
Best Timing for Neonatal Gastrostomy with Tracheostomy
A recent clinical review evaluates the optimal timing for performing neonatal gastrostomy concurrently with tracheostomy. The authors compare outcomes of simultaneous versus staged procedures, highlighting reduced anesthesia exposure and shorter intensive care stays when both are done together. Data from...
GSK Delivers in New CEO Miels' First Financial Update
Luke Miels’ first financial update as GSK chief executive shows an 8% rise in fourth‑quarter sales to £8.62 bn, lifting full‑year revenue 7% to £32.67 bn. Growth was driven by new launches such as Blenrep, Nucala and Exdensur, and a pipeline bolstered...
Expert Intelligence Raises $4.7M to Automate Decision-Making in Laboratory Environments
Expert Intelligence announced a $4.7 million seed round to commercialize its Limited Sample Model (LSM), an AI platform that automates decision‑making in regulated laboratory environments. LSM learns from as few as 30 representative samples, enabling labs to transform raw instrument data...
Novartis Says Generics to Erode $4B From 2026 Sales
Novartis announced that generic competition will erode about $4 billion from its 2026 sales, primarily affecting three blockbuster drugs. The heart‑failure medication Entrezto, its top seller, will see its first generic entry in the fourth quarter of 2026. The company warned...
Decoding Neural Population Geometry in Shared Tasks
Researchers in Nature Neuroscience reveal how neural populations encode multiple tasks using shared geometric structures. By mapping firing rates into high‑dimensional spaces, they show that tasks with latent commonalities are represented in low‑dimensional subspaces, while task‑specific components occupy orthogonal higher‑dimensional...
Lilly Beats Sales Forecasts, Plots Major Growth in 2026 in Stark Contrast to Novo
Eli Lilly reported fourth‑quarter 2025 revenue that topped analysts’ forecasts, signaling a stronger‑than‑expected performance. The company also projected a sizable revenue increase for 2026, driven by upcoming product launches and an expanding oncology pipeline. This upbeat guidance contrasts sharply with Novo Nordisk’s...
Sugar Molecules Offer Promising New Approach to Combat Drug-Resistant Bacteria
Australian researchers have engineered antibodies that bind to pseudaminic acid, a sugar molecule found exclusively on the surface of many pathogenic bacteria. The pan‑specific antibody demonstrated potent clearance of multidrug‑resistant Acinetobacter baumannii in mouse infection models. By targeting a bacterial...
Crab Shell Gel Turns Kimchi Bacteria Into Living Food Safety Sensors
Researchers at Rice University engineered a naphthoquinone‑grafted chitosan hydrogel that embeds the food‑grade bacterium Lactiplantibacillus plantarum, achieving extracellular electron transfer 15.6 times higher than plain chitosan. The tethered quinone mediators stay fixed, preventing leakage and stabilizing performance for up to...
Unlocking History: Genetic Study of Deep Maniot Greeks Unveils a Unique Balkan Time Capsule
A new study in Communications Biology reveals that the Deep Maniot Greeks of Greece's Mani Peninsula have maintained a remarkably isolated gene pool for over a millennium. Uniparental Y‑chromosome and mitochondrial DNA analyses show continuity from Bronze Age, Iron Age...
The First Clinical Trial of Partial Reprogramming Will Start Soon
The FDA has cleared Life Bioscience’s ER-100 for the first human trial of partial epigenetic reprogramming, aimed at restoring damaged retinal cells in patients with open‑angle glaucoma and non‑arteritic anterior ischemic optic neuropathy. The therapy delivers three Yamanaka factors—Oct4, Sox2...
Ferroptosis in Alzheimer's Disease Is Reduced by Exercise
Recent review highlights ferroptosis, an iron‑dependent lipid‑peroxidation cell death, as a key driver of neuronal loss in Alzheimer’s disease. Senescent cells disrupt iron homeostasis, antioxidant defenses, and autophagy, creating a pro‑ferroptotic brain environment that accelerates pathology. Physical exercise counteracts these...
Embattled Novo Nordisk Considers Buying a Monthly GLP-1 to Bolster Portfolio
Novo Nordisk is actively exploring the acquisition or internal development of a long‑acting, once‑monthly GLP‑1 therapy. The move aims to counter Pfizer’s newly launched monthly obesity injection and to broaden Novo’s weight‑loss portfolio. Executives see a monthly formulation as a...
Assessing Coronary Lesions in Kawasaki Disease via Angiography
Researchers Chen, Feng and Zhang used coronary angiography to map coronary artery lesions in children with Kawasaki disease, revealing a spectrum from mild stenosis to large aneurysms. The study identified younger age at onset and delayed IVIG treatment as key...
Anthropic Partners with Leading Research Institutes to Tackle Biology's Data Bottleneck
Anthropic has struck partnerships with the Allen Institute and the Howard Hughes Medical Institute to build AI agents that tackle biology’s growing data bottleneck. The collaborations will develop specialized agents for experiment design, data integration, and instrument control, aiming to...
Polymer‐Coated Manganese Dioxide Nanoparticles for Foliar Mn Delivery: Mechanisms of Uptake and Metabolic Responses in Mn Deficient Barley
Researchers demonstrated that ~25 nm polyacrylic acid‑coated MnO₂ nanoparticles can rapidly penetrate barley leaves through stomata when applied as a foliar spray. Within two hours the particles dissolve, releasing Mn²⁺ that restores photosynthetic efficiency in Mn‑deficient plants without causing phytotoxicity, even...
Hydrophobic Drug-Loaded pRNA Nanoparticles Target Tumors Safely
Researchers have engineered branched four‑way junction (4WJ) RNA nanoparticles that can conjugate up to 24 hydrophobic chemotherapeutic molecules, including camptothecin and paclitaxel. The RNA platform boosts paclitaxel’s water solubility by roughly 32,000‑fold and uses click‑chemistry ester linkers that cleave in...
Engineered Nanofiber‐Based Nerve Guidance Conduit Facilitates the Restoration of Peripheral Nerve Injury Through Enhanced Vascularization
Researchers engineered a nerve guidance conduit (NGC) by coating electrospun polycaprolactone (PCL) nanofibers with endothelial cell‑derived matrix (ECd). The ECd@PCL scaffold provides oriented physical cues and bioactive signals that boost axonal extension in PC12 cells and improve intercellular communication in...
Assessing Performance Management in Malawi’s Primary Healthcare
Malawi’s Ministry of Health launched a nationwide performance‑management review for primary‑care facilities, integrating real‑time data dashboards and quarterly scorecards. The pilot, covering 150 clinics across three districts, showed a 12% increase in routine immunisation coverage and a 9% reduction in...
HHS Is Making an AI Tool to Create Hypotheses About Vaccine Injury Claims
The U.S. Department of Health and Human Services is creating a generative‑AI tool to scan the Vaccine Adverse Event Reporting System (VAERS) and automatically generate hypotheses about potential vaccine injuries. The system, listed in HHS’s 2025 AI inventory, builds on...
Fears US Drug Pricing Deal Will Weigh Heavy on the NHS
UK Science Minister Sir Patrick Vallance confirmed that the £1 billion three‑year drug pricing deal with the United States will be funded from the Department of Health and Social Care budget, not the Treasury. The agreement keeps US tariffs on UK‑origin...
Thomas Farrell
NanoSyrinx, a synthetic‑biology firm developing nanosyringe platforms for intracellular delivery, announced Thomas J. Farrell as its new Chief Executive Officer and Director, succeeding founder Joe Healey. Farrell brings more than 25 years of biotherapeutics leadership, having founded two NASDAQ‑listed companies...
How a Heart Medication Could Unlock a New Targeted Approach in Lymphoma
Researchers at VCU Massey Cancer Center identified dronedarone, an FDA‑approved heart medication, as a selective inhibitor of the deubiquitinase USP11, targeting its non‑catalytic UBL domain. The compound, named RBF4, demonstrated potent activity against MYC‑driven diffuse large B‑cell lymphoma in preclinical...
Induced-Fit Growth of Ga Semiconductors for Neuromorphic Devices
Researchers introduced an “induced fit” growth technique that produces gallium‑based semiconductor thin films capable of atomic‑scale adaptation to substrates. The resulting films exhibit defect‑free crystal structures, high electron mobility, and robust performance under mechanical deformation, enabling flexible neuromorphic and optoelectronic...
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
Rare disease drug development is poised for rapid expansion, with the market projected to reach $400‑600 billion by the early‑to‑mid 2030s. Recent FDA guidances, including the plausible‑mechanism approval pathway, aim to accelerate cell and gene therapy approvals for ultrarare conditions. Executives...
Reprogramming T Cells to Cross the Brain’s Border
In this episode, host and guest Michael Roberts, co‑founder and CEO of Adaptin Bio, discuss the difficulty of delivering biologic therapies across the blood‑brain barrier for glioblastoma patients. Roberts explains Adaptin’s platform, which reprograms a patient’s own T cells to...
Shaping the Future of Microbial Development: From Gene to GMP
Fujifilm Biotechnologies is hosting a free webinar titled “Shaping the Future of Microbial Development: From Gene to GMP.” The session, led by Steve Loftus, PhD, will showcase proven strategies and emerging technologies that accelerate microbial fermentation, scale‑up, and regulatory readiness....
Minimally Invasive Luciferases for Precise Tumor Tracking
Researchers at the BioInnovate Institute have unveiled a suite of engineered luciferases that emit near‑infrared light, allowing minimally invasive, high‑resolution tumor tracking in live animals. The new enzymes deliver up to three‑fold greater signal intensity than conventional firefly luciferase, while...
Does Waiting Influence Patient Revisit Decisions?
A new BMC Health Services Research study by Liu and Zhao examines how waiting time shapes patients' willingness to return to fever clinics in post‑epidemic China. Using empirical data from multiple clinics, the authors find that both the actual duration...
2021 Sparked a Banner Year for Biotech IPOs. Where Are They Now?
In 2021 a pandemic‑driven gold rush produced 99 biotech IPOs that raised $15.6 billion, dwarfing the combined proceeds of 2023‑24. The surge created a “logical gap,” with many companies going public before their science was mature, leading to bankruptcies, pivots, and...
Editor Shares Insights at Nanotech Conference Plenary
Wrapping up two days at the 10th biennial International Conference on Nanoscience and Nanotechnology here in Sydney, Australia. Highly engaging event, where my participation involved serving on a panel discussion with other journal editors and delivering a plenary presentation on our...
Novo Drops, Eli Lilly Rebounds—GLP‑1 Earnings Cycle Repeats
GLP-1 earnings reports playbook: 1) $NVO: Guys, it’s not looking great for GLP-1 sellers ***$NVO and $LLY sell off*** 2) $LLY: Huh? Nah we’re good. ***$NVO stays down $LLY rips*** 3) Repeat
FDA Seeks Withdrawal of Amgen's Tavneos, Company Says It Won't Pull Drug
The U.S. Food and Drug Administration has formally asked Amgen to withdraw its rare‑disease therapy Tavneos from the market, citing unresolved safety and manufacturing concerns. Amgen’s CEO Bob Bradway publicly rejected the request, stating the company will continue to sell...
Novartis Halts PIT565 T‑cell Engager Development
Confirmned discontinuation of $NVS PIT565, which seems to be a specifically targeted T-cell engager (also hit CD2). cf $AZN Titan platform.
DSNKY's DS-3790 DXd ADC Begins Clinical Trials
$DSNKY's first DXd ADC for haematology, DS-3790, enters the clinic. As I reported last November: https://t.co/9CcbISqbqK
How Urban Environments Enabled Spotted Lanternflies to Flourish in the US
The spotted lanternfly, an invasive pest native to Asia, has rapidly expanded across the United States as urban environments provide ideal habitats and dispersal pathways. Cities offer abundant host trees, heat islands, and fragmented green spaces that accelerate breeding cycles...
New Antibody‑Drug Conjugates Unveiled in Latest Scoop
Several scoops among the latest ADC names. Via @ApexOnco with H/T to @raffcolo -> https://t.co/JxDmId0Q0A
MRK's Interpath-001 Study Fully Enrolled
$MRK confirming that Interpath-001 study of $MRNA partnered intismeran autogene is "ongoing & fully enrolled". No further guidance as to timing of results, due some time in 2026. My earlier take on what to expect: https://t.co/9Pk3JK8TLs
Mold Exposure Linked to Arthritis in Older Chinese Adults
A new epidemiological study of 5,000 Chinese adults over 60 finds a statistically significant association between chronic indoor mold exposure and increased prevalence of rheumatoid arthritis. Researchers measured mold levels using home inspections and questionnaires, linking higher spore counts to...
Reproduction in Space, an Environment Hostile to Human Biology
A new study in Reproductive Biomedicine Online warns that space’s radiation, microgravity and circadian disruption create a hostile environment for human reproduction. It highlights the absence of industry‑wide standards for managing fertility risks, early pregnancy, and ethical dilemmas as commercial...
Novel Selective Morpholine Trace Amine-Associated Receptor 1 Partial Agonists Show Promising Preclinical Effects for Neuropsychiatric Disorders and Are Well Tolerated...
Roche researchers have disclosed a new series of selective morpholine‑based trace amine‑associated receptor 1 (TAAR1) partial agonists that demonstrate robust antipsychotic, antidepressant and anti‑addiction activity in preclinical models. The compounds were advanced into a Phase‑1 study in healthy volunteers, where they...